title: [Effect of timolol on central corneal thickness and endothelial cell density].
abstract: BACKGROUND
  The measurement of corneal thickness plays an increasing role in glaucoma screening and diagnosis. The influence of a variety of drugs on corneal thickness is well established. Especially for antiglaucomateous drugs this effect seems to be important. However, little is known about the influence of beta receptor antagonists on corneal thickness. The aim of this study was to provide evidence of the effect of timolol on central corneal thickness and endothelial cell density.
  
  
  METHODS
  Ten healthy volunteers (five women and five men) with a mean age of 29 years (range 25 to 56 years) were examined in a double-blind, prospective and randomised pilot study. Intraocular pressure, corneal thickness and endothelial cell density was estimated before as well as fifteen minutes, 24, 48, 72 and 96 hours after application of timolol 0.5 % eye drops twice daily. The partner eye received sodium hyaluronate eye drops twice daily and served as a control.
  
  
  RESULTS
  The application of timolol showed a decrease of intraocular pressure from initially 12 mmHg to 9 mmHg after four days (p = 0,0188) as well as an increase of corneal thickness from 537 microm to 557 microm after four days (p = 0,0659). There was no change of intraocular pressure (p = 0,9935) or corneal thickness (p = 0,9998) in the control eyes. There was also no effect of timolol (p = 0,2782) or sodium hyaluronate (p = 0,1940) on endothelial cell density.
  
  
  CONCLUSIONS
  The study provides evidence of the influence of beta receptor antagonists on corneal thickness. This effect may be caused by receptor mediated influences on corneal ion and fluid transport. Further studies are needed to show if the increase of corneal thickness after application of topical timolol has clinical importance.
authors.affiliation: Universitätsaugenklinik Tübingen, Abteilung I, Schleichstrasse 12, 72076 Tübingen. matthias_grueb@yahoo.de
authors.forename: M
authors.initials: M
authors.lastname: Grüb
authors.forename: M
authors.initials: M
authors.lastname: Leitritz
authors.forename: J
authors.initials: J
authors.lastname: Mielke
authors.forename: E
authors.initials: E
authors.lastname: Reinthal
authors.forename: K U
authors.initials: KU
authors.lastname: Bartz-Schmidt
authors.forename: J M
authors.initials: JM
authors.lastname: Rohrbach
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D002452:Cell Count; D003315:Cornea / Q000033:anatomy & histology* / Q000187:drug effects / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D042783:Endothelial Cells / Q000166:cytology* / Q000187:drug effects*; D005260:Female; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D013999:Timolol / Q000008:administration & dosage*
chemical_list: D000959:Antihypertensive Agents; D013999:Timolol